The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, Capecitabine
- 27 July 2000
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 8 (7) , 1697-1706
- https://doi.org/10.1016/s0968-0896(00)00087-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissuePublished by Elsevier ,1998
- A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a RegimenEuropean Journal Of Cancer, 1998
- Prodrugs of anticancer agentsAdvanced Drug Delivery Reviews, 1996
- Comparative Antitumor Activity and Intestinal Toxicity of 5′-Deoxy-5-fluorouridine and Its Prodrug Trimethoxybenzoyl-5′-deoxy-5-fluorocytidineJapanese Journal of Cancer Research, 1990
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Structural Requirements for the Enzymatic Deamination of Cytosine NucleosidesHelvetica Chimica Acta, 1978
- Synthesis of nucleosides. 9. General synthesis of N-glycosides. I. Synthesis of pyrimidine nucleosidesThe Journal of Organic Chemistry, 1974
- Purification and Properties of Cytidine Deaminase from Normal and Leukemic GranulocytesJournal of Clinical Investigation, 1974
- Deoxycytidylate Deaminase and Deoxycytidine Deaminase in Normal and Neoplastic Human TissuesEnzymologia Biologica Et Clinica, 1970
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965